Adam Powell, Ph.D.

AdamPowell 200x300 Adam Powell, Ph.D.

Managing Partner & President:

Areas of Expertise:

Healthcare reform
Health IT
Provider claims analysis
Medical technology purchasing

contact1 Adam Powell, Ph.D.


Ph.D., The Wharton School of the University of Pennsylvania, Health Care Management & Economics
M.A., The Wharton School of the University of Pennsylvania, Health Care Management & Economics
S.B., Massachusetts Institute of Technology Sloan School of Management, Management Science
S.B., Massachusetts Institute of Technology, Writing


Adam C. Powell, Ph.D., is a healthcare economist known for his expertise in healthcare finance, healthcare technology adoption, and operationally-oriented problem solving. Dr. Powell is a member of the adjunct faculty of Northeastern University, where he teaches students in the Health Informatics Graduate Program. During March 2013, he served on the Visiting Faculty of the Indian School of Business, where he taught a post-graduate course on Health IT. Dr. Powell’s insights have been featured on CNN, Forbes, NBC News, Reuters, Fox Business, The Christian Science Monitor, Yahoo! Finance, Becker’s Hospital Review, Healthcare Finance News, and numerous other outlets.

Dr. Powell has consulted for three of the five largest health insurance networks and is an active member of the Healthcare Council of the consulting firm Gerson Lehrman Group (GLG). Prior to founding Payer+Provider, Dr. Powell built the payer practice of Penn Biotech Group. Over his career, he has worked for Humana, Microsoft, Oliver Wyman Health & Life Sciences, and UBS Wealth Management USA. Outside of work, he exhibits art and studies Mandarin Chinese.

Key Research Findings:

Trauma departments capture less revenue per patient when under high workload.
“Physician Workload and Hospital Revenue: Overworked Physicians Generate Less Revenue Per Patient”

A hospital’s uncertainty over whether a CT machine will meet customer desires more strongly influences its purchasing decision than its uncertainty over whether it will meet financial objectives.
“Perspectives on Firm Decision Making During Risky Technology Acquisitions”